| Field | Specification |
|---|---|
| Mfr No | |
| Clonality | |
| Host | |
| Immunogen | E.coli-derived human SV2C recombinant protein (Position: M1-A579) was used as the immunogen for the SV2C antibody. |
| Isotype | |
| Product Type | |
| Purity | |
| Reactivity | |
| Storage | |
| Target | |
| UniProt # |
Overview
SV2C Antibody / Synaptic vesicle glycoprotein 2C is an antibody targeting SV2C. Host: Rabbit. Polyclonal. Format: Lyophilized. Applications: WB, FACS, ELISA.
Key elements and design rationale
- Target: SV2C.
- Immunogen: E.coli-derived human SV2C recombinant protein (Position: M1-A579) was used as the immunogen for the SV2C antibody..
- Species reactivity: Human, Mouse, Rat.
- Conjugate: Unconjugated (no label listed).
Biological background (from provided description)
SV2C antibody detects Synaptic vesicle glycoprotein 2C, encoded by the SV2C gene. Synaptic vesicle glycoprotein 2C is a member of the synaptic vesicle protein family that regulates neurotransmitter release and synaptic transmission.
Common research applications
- WB: relative abundance and band pattern assessment using appropriate controls.
Notes for experimental interpretation
- Account for isoforms, paralogs, and post-translational modifications when interpreting signal.
- Support specificity with biological controls (e.g., KO/KD where available) and technical controls (e.g., secondary-only/isotype).
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
